Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BETAMETHASONE DIPROPIONATE for Pustular psoriasis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where BETAMETHASONE DIPROPIONATE was used for Pustular psoriasis.

Most Reported Side Effects for BETAMETHASONE DIPROPIONATE

Side Effect Reports % Deaths Hosp.
Drug ineffective 1,034 40.7% 41 198
Macular degeneration 522 20.5% 0 122
Off label use 330 13.0% 99 201
Condition aggravated 280 11.0% 132 166
Therapeutic product effect incomplete 251 9.9% 45 184
Product use in unapproved indication 230 9.1% 59 67
Pain in extremity 229 9.0% 44 90
Nausea 200 7.9% 71 164
Pain 192 7.6% 21 127
Dyspnoea 173 6.8% 93 139
Erythema 156 6.1% 0 85
Pneumonia 155 6.1% 24 43
Abdominal pain 152 6.0% 68 140
Constipation 143 5.6% 62 132
Pyrexia 142 5.6% 22 134

Other Indications for BETAMETHASONE DIPROPIONATE

Product used for unknown indication (1,125) Psoriasis (226) Eczema (97) Swelling (88) Dermatitis atopic (62) Rash (54) Gingivitis (45) Pruritus (42) Maternal therapy to enhance foetal lung maturity (39) Dermatitis (25)

Other Drugs Used for Pustular psoriasis

APREMILAST (349) SECUKINUMAB (317) ADALIMUMAB (207) METHOTREXATE (159) CYCLOSPORINE (157) ETANERCEPT (146) INFLIXIMAB (144) ACITRETIN (129) USTEKINUMAB (120) EFALIZUMAB (101)

Related Pages

BETAMETHASONE DIPROPIONATE Full Profile All Pustular psoriasis Drugs BETAMETHASONE DIPROPIONATE Demographics BETAMETHASONE DIPROPIONATE Timeline